Received Oct 20, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TDAP | TDAP (BOOSTRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | k4979 | IM / LA |
Systemic: Dizziness / Lightheadness-Severe, Systemic: Fainting / Unresponsive-Severe, Systemic: Flushed / Sweating-Severe, Systemic: Hypotension-Medium, Additional Details: Patient lost conciousness following immunization and regained conciousness within 60 seconds. Patient was monitored for 30 minutes following loss of conciousness. No epinephrine or benadryl was given. Blood pressure was 97/60 post fainting and came back up to 110/78 within 5 minutes. , Other Vaccines: VaccineTypeBrand: Spikevax 2025-26 (COVID); Manufacturer: Moderna; LotNumber: 8146743; Route: IM; BodySite: LA; Dose: ; VaxDate: UNKNOWN, VaccineTypeBrand: Fluarix 2025-26; Manufacturer: Glaxosmithkline; LotNumber: 73BN2; Route: IM; BodySite: LA; Dose: ; VaxDate: UNKNOWN